TABLE 4.

Factors predicting continuation/cessation of opicapone among 57 patients prescribed opicapone

Variable	β coefficient	SE	P value	Exp (β)	CI Exp (β)
					Lower	Upper
Age at opicapone onset (yr)	0.03	0.04	0.47	1.03	0.96	1.11
Disease duration at opicapone onset (yr)	0.12	0.07	0.08	1.13	0.98	1.30
Daily OFF time at baseline (hr)	0.22	0.13	0.09	1.24	0.97	1.59
Entacapone switchers vs. previously stopped at baseline	0.84	0.70	0.23	2.3	0.59	9.2